Bayer today showcased significant advancements in its pharmaceutical growth strategy and pipeline at its recent annual Pharma ...

The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.

Bayer's AI Innovation Platform (AIIP), powered by Google Cloud technology, streamlines the development of AI-driven medical ...

The FDA converts its accelerated approval to full approval for BAYRY's oncology drug, Vitrakvi, on positive data from ...

Bayer said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with ...

Bayer heralds pipeline progress, blockbuster launches and advanced flagship products in cell-gene therapy: Our Bureau, Bengaluru Wednesday, April 2, 2025, 14:50 Hrs [IST] Bayer Ph ...

Talking about the importance of science in agriculture, Emma Manolache, Public Affairs Lead for Romania, Bulgaria and ...

Antihemophilic Factor binds factor IXa along with calcium and phospholipid. This complex converts factor X to factor Xa to ...